Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuHuangLianzonggan in NASH
NCT05632861Phase 2Recruiting
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Botanical medicine
- Countries
- 1
01
Overview
A Phase 2 trial of HuHuangLianzonggan capsule in Nonalcoholic steatohepatitis (NASH), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Feb 2023; status: recruiting.
02
Drugs
HuHuangLianzonggan capsule
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05632861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05632861.